UPC cases at the Milan CD
52 cases before the Milan CD at the Unified Patent Court, most recently decided first.
| Decided | Filed | Case | Division | Category | Claimant | Respondent |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jun 3, 2026 | UPC CFI 1968/2026 | Milan CD | Procedural | Gilead Sciences, Inc. | Academy of Military Medical Sciences |
| Jun 12, 2026 | — | UPC CFI 1230/2026 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| May 27, 2026 | Sep 15, 2025 | UPC CFI 860/2025 | Milan CD | Revocation | LS 9 GmbH | bellissa HAAS GmbH |
| May 4, 2026 | Jun 18, 2025 | UPC CFI 552/2025 | Milan CD | Revocation | Gilead Sciences, Inc. | Academy of Military Medical Sciences |
| Mar 13, 2026 | Aug 8, 2025 | UPC CFI 722/2025 | Milan CD | Revocation | Neurocrine Biosciences, Inc. | Spruce Biosciences, Inc. |
| Mar 13, 2026 | Sep 25, 2025 | UPC CFI 927/2025 | Milan CD | Revocation | La Siddhi Consultancy Limited | Athena Pharmaceutiques SAS +1 |
| Jan 15, 2026 | May 29, 2025 | UPC CFI 480/2025 | Milan CD | Revocation | Fisher & Paykel Healthcare Limited | Flexicare (Group) Limited |
| Dec 4, 2025 | Oct 14, 2025 | UPC CFI 1167/2025 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| Nov 27, 2025 | Oct 23, 2024 | UPC CFI 613/2024 | Milan CD | Revocation | Pari Pharma GmbH | Koninklijke Philips N.V. |
| Oct 23, 2025 | Sep 30, 2024 | UPC CFI 497/2024 | Milan CD | Revocation | bioMérieux UK Limited | Labrador Diagnostics LLC |
| Oct 16, 2025 | Sep 26, 2025 | UPC CFI 941/2025 | Milan CD | Procedural | Herbert Smith Freehills Kramer LLP | EOFLOW Co., Ltd. +1 |
| Oct 15, 2025 | Aug 21, 2025 | UPC CFI 774/2025 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| Sep 4, 2025 | — | UPC APP 34350/2025 | Milan CD | Procedural | Gilead Sciences, Inc. | Academy of Military Medical Sciences |
| Aug 6, 2025 | — | UPC APP 32529/2025 | Milan CD | Appeals | Bodycap +2 | EPO (Office européen des brevets) |
| Jul 22, 2025 | — | CC 65201/2024 | Milan CD | Infringement | Insulet Corporation | EOFLOW Co., Ltd. |
| Jul 18, 2025 | — | ACT 48305/2024 | Milan CD | Revocation | bioMérieux UK Limited +6 | Labrador Diagnostics LLC |
| Jul 18, 2025 | — | CC 54050/2024 | Milan CD | Revocation | Labrador Diagnostics LLC | bioMérieux SA +5 |
| Jun 5, 2025 | — | UPC APP 25415/2025 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| May 15, 2025 | Sep 5, 2024 | UPC CFI 513/2024 | Milan CD | Infringement | Maschio Gaspardo S.p.A. | Spiridonakis Bros GP |
| Apr 23, 2025 | — | ORD 19201/2025 | Milan CD | Procedural | Labrador Diagnostics LLC | bioMérieux SA +5 |
| Apr 22, 2025 | — | UPC APP 16366/2025 | Milan CD | Procedural | Pfizer, Inc. +15 | GlaxoSmithKline Biologicals SA |
| Apr 22, 2025 | — | UPC APP 17607/2025 | Milan CD | Procedural | Pfizer, Inc. +7 | GlaxoSmithKline Biologicals SA |
| Apr 22, 2025 | — | UPC APP 17784/2025 | Milan CD | Procedural | Pfizer, Inc. +7 | GlaxoSmithKline Biologicals SA |
| Apr 11, 2025 | — | ACT 56003/2024 | Milan CD | Revocation | Insulet Corporation | EOFLOW Co., Ltd. |
| Apr 11, 2025 | Oct 14, 2024 | UPC CFI 597/2024 | Milan CD | Revocation | EOFLOW Co., Ltd. | Insulet Corporation |
| Apr 10, 2025 | Feb 27, 2025 | UPC APP 10151/2025 | Milan CD | Procedural | ALIUD PHARMA GmbH | Accord Healthcare B.V. +3 |
| Mar 21, 2025 | — | UPC APP 9038/2025 | Milan CD | Procedural | Zentiva, k.s. +1 | Accord Healthcare B.V. +3 |
| Feb 27, 2025 | — | UPC APP 5729/2025 | Milan CD | Procedural | SharkNinja Italy S.R.L. | Dyson Technology Limited |
| Feb 15, 2025 | — | UPC APP 5366/2025 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| Feb 15, 2025 | Dec 12, 2024 | UPC APP 65673/2024 | Milan CD | Procedural | EOFLOW Co., Ltd. | Insulet Corporation |
| Feb 3, 2025 | Dec 30, 2024 | UPC APP 68658/2024 | Milan CD | Procedural | STADAPHARM GmbH | Accord Healthcare B.V. +3 |
| Feb 3, 2025 | Nov 14, 2024 | UPC CFI 698/2024 | Milan CD | Procedural | Accord Healthcare B.V. +2 | Novartis AG |
| Dec 23, 2024 | Oct 24, 2024 | UPC APP 58027/2024 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| Dec 3, 2024 | — | UPC APP 56246/2024 | Milan CD | Other | GlaxoSmithKline Biologicals SA | Pfizer Manufacturing Belgium NV +7 |
| Oct 1, 2024 | Jul 3, 2024 | UPC CFI 380/2024 | Milan CD | Provisional | Insulet Corporation | EOFLOW Co., Ltd. |
| Sep 24, 2024 | — | UPC APP 50666/2024 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| — | Nov 14, 2025 | UPC CFI 1587/2025 | Milan CD | Revocation | BIOGARAN | H. Lundbeck A/S |
| — | Jul 6, 2026 | UPC CFI 2433/2026 | Milan CD | Infringement | Maschio Gaspardo S.p.A. | Animex Ltd +3 |
| — | Jul 24, 2026 | UPC CFI 2680/2026 | Milan CD | Revocation | LABORATOIRES SVR +3 | Beiersdorf Aktiengesellschaft |
| — | Jan 28, 2026 | UPC CFI 292/2026 | Milan CD | Revocation | Light Guide Optics International | biolitec Holding GmbH & Co. KG |
| — | Apr 29, 2025 | UPC CFI 382/2025 | Milan CD | Procedural | Novartis AG | Zentiva, k.s. +1 |
| — | Aug 14, 2024 | UPC CFI 476/2024 | Milan CD | Revocation | Pfizer, Inc. +7 | GlaxoSmithKline Biologicals SA |
| — | May 28, 2025 | UPC CFI 477/2025 | Milan CD | Procedural | Insulet Corporation | EOFLOW Co., Ltd. |
| — | Sep 30, 2024 | UPC CFI 571/2024 | Milan CD | Revocation | bioMérieux Benelux BV +5 | Labrador Diagnostics LLC |
| — | Oct 21, 2024 | UPC CFI 604/2024 | Milan CD | Revocation | SharkNinja Italy S.R.L. | Dyson Technology Limited |
| — | Jul 8, 2025 | UPC CFI 628/2025 | Milan CD | Appeals | Bodycap +2 | — |
| — | Oct 31, 2024 | UPC CFI 642/2024 | Milan CD | Revocation | AMGEN Switzerland AG Vilniaus filialas | Alexion Pharmaceuticals, Inc. |
| — | Nov 15, 2024 | UPC CFI 687/2024 | Milan CD | Revocation | Pfizer S.r.l. +7 | GlaxoSmithKline Biologicals SA |
| — | Aug 13, 2025 | UPC CFI 742/2025 | Milan CD | Revocation | BEGA BBK Sp. z o.o. sp. K | Washtower IP B.V. |
| — | Aug 21, 2025 | UPC CFI 773/2025 | Milan CD | Other | Insulet Corporation | EOFLOW Co., Ltd. |
See outcome rates, preliminary injunction statistics and full analytics
Create a free UPClytics account to unlock outcome analytics, judge and firm scorecards, filters and comparisons across every UPC proceeding.